Did Yuanbao beat or miss consensus estimates last quarter?

What factors drove the changes in Yuanbao's revenue and profit?

What is Yuanbao's latest dividend and current dividend yield?

What were the key takeaways from Yuanbao’s earnings call?

What is the revenue and EPS growth rate for Yuanbao year over year?

What guidance did Yuanbao's management provide for the next earnings period?

What is the market's earnings forecast for Yuanbao next quarter?

What does Yuanbao do and what are its main business segments?

- **Revenue Surge**: Q4 2025 revenue up 32.2% YoY to RMB 1.18 billion, driven by AI-integrated insurance distribution and system services.
- **Profitability Strength**: 14 consecutive quarters of net income growth, with full-year net margin improving to 29.9%.
- **AI-Driven Efficiency**: AI agents now handle 30%+ of customer interactions, reducing costs and improving service consistency.
- **Policy Catalysts**: National drug catalog expansion and long-term care insurance mandates create RMB 10+ billion market opportunity for inclusive insurance products.
- **Growth Momentum**: 2026 guidance for stable marketing costs as % of revenue, with focus on AI-driven customer acquisition and retention.


**【CEO Summary Section】**
- **Revenue Growth**: Q4 2025 revenue reached RMB 1.18 billion, up 32.2% YoY. Full-year revenue was RMB 4.37 billion, up 33.1% YoY.
- **Profitability**: Q4 net income of RMB 337.4 million (15.4% YoY growth), with 14 consecutive quarters of profitability. Full-year net income was RMB 1.31 billion (51% YoY growth).
- **AI Expansion**: AI team now 10% of workforce; model network includes 4,900+ models analyzing 5,000+ labels. AI agents used in presales, customer service, and claims processing.
- **Policy Impact**: New policies reached 7.9 million in Q4 (34.5% YoY), and 30.7 million annually (36.7% YoY). Focus on underserved segments like women, new urban residents, and pre-existing condition holders.
- **Cash Position**: RMB 4.04 billion in cash reserves, up 72.9% YoY.

**【CFO Financial Commentary】**
- **Revenue Breakdown**: Q4 insurance distribution revenue RMB 401.1 million (35.1% YoY), system services RMB 774.1 million (31.1% YoY). Full-year insurance distribution up 33.8% to RMB 1.45 billion, system services up 33.2% to RMB 2.92 billion.
- **Expenses**: Q4 operating expenses RMB 780.4 million (30.2% YoY). R&D up 39.1% to RMB 111.7 million. Full-year R&D up 58% to RMB 365.1 million.
- **Profitability**: Q4 non-GAAP net income RMB 354.5 million (13.2% YoY). Full-year non-GAAP net income RMB 1.38 billion (48.6% YoY).
- **Cash Flow**: Q4 operating cash inflow RMB 290.7 million; full-year RMB 1.5 billion.

**【Q&A Key Highlights】**
- **2026 Outlook**: Management expects to maintain revenue and profit growth momentum, driven by tech-enabled efficiency and scale.
- **Marketing Efficiency**: Selling & marketing expenses grew 47.7% YoY in Q4 but improved efficiency through AI-driven targeting. 2026 aim to keep marketing costs as % of revenue stable.
- **Customer Retention**: Renewal rates stable; focus on product innovation (e.g., zero-deductible medical insurance), user education, and claim ratio improvements.
- **AI Threats**: Competitors' AI agents may disrupt traditional sales channels, but Yuanbao's discovery-based platform (content-driven engagement) provides a competitive edge.
- **Policy Tailwinds**: National Commercial Insurance Innovative Drug Catalog expansion and long-term care insurance system support commercial health insurance growth. Yuanbao partners with insurers to expand drug coverage in Super Medical Insurance products.


Yuanbao Inc. American Depositary Shares(YB)-20260318-2025 Q4 Earnings call transcript

- **Revenue Surge**: Q3 revenue up 33.6% YoY to RMB 1.16 billion, net income jumps 51.3% YoY to RMB 370 million.
- **AI-Driven Efficiency**: AI-generated code accounts for 50% of new code, reducing R&D costs and improving customer service automation.
- **Innovative Product Launch**: New critical illness insurance model lowers prices by 30% while expanding coverage, targeting underserved markets.
- **Cash Strength**: RMB 3.75 billion cash (82.3% YoY growth) supports strategic investments and 30%+ revenue growth guidance for 2025.
- **Sustainability Focus**: Balancing growth with profitability, with net income margin expanding to 32% and non-GAAP margin at 33.7%.


**【CEO Summary Section】**
- **Revenue Growth**: Total revenue reached RMB 1.16 billion, up 33.6% YoY, driven by 41.8% YoY increase in new policies issued (8 million). Net income surged 51.3% YoY to RMB 370 million.
- **AI Integration**: Embedded large language models (LLMs) into R&D, customer service, and claims processing. AI-generated code accounted for 50% of new code in Q3, improving operational efficiency.
- **Product Innovation**: Launched a short-term critical illness insurance product with parallel lump-sum payment and reimbursement, targeting underserved markets. This model lowers prices while expanding coverage.
- **Cash Position**: Ended Q3 with RMB 3.75 billion in cash, up 82.3% YoY, supporting strategic investments and growth.

**【CFO Financial Commentary】**
- **Revenue Breakdown**: Insurance distribution revenue grew 27.9% YoY to RMB 373.3 million; system services revenue rose 36.9% YoY to RMB 783.5 million, driven by AI-enhanced solutions.
- **Expenses**: Total operating expenses increased 31.2% YoY to RMB 803.4 million. R&D expenses rose 56.8% YoY to RMB 95.6 million, reflecting investment in AI and technology.
- **Profitability**: Net income margin expanded to 32% (vs. 28.2% YoY), with non-GAAP net income margin at 33.7%. Operating cash flow was RMB 326.1 million.

**【Q&A Highlights】**
- **Marketing Efficiency**: Selling & marketing expenses as % of revenue improved due to dynamic strategy adjustments and AI-driven targeting. Management expects sustained efficiency despite potential industry-wide ad cost increases.
- **AI Impact**: LLMs improved R&D productivity (e.g., 1,000+ AI-generated technical documents) and customer service automation. AI is core to long-term competitive advantage.
- **Competition & Strategy**: Focus on operational efficiency and AI-driven engine optimization. Independent platform model allows cross-industry collaboration, unlike ecosystem players.
- **Future Growth**: 3 key drivers: market tailwind (aging population, health insurance penetration), cross-selling innovation, and data-driven model refinement. 2025 full-year revenue growth guidance of at least 30%.


Yuanbao Inc. American Depositary Shares(YB)-20251203-2025 Q3 Earnings call transcript

- **Revenue Surge**: Q2 2025 revenue up 25.2% YoY to RMB 1.07 billion, net income jumps 55.6% YoY to RMB 305 million.
- **AI-Driven Efficiency**: AI agents cut manual tasks by 30%, RAG accuracy up 25%, voice emotion models boost satisfaction by 15%.
- **Strategic Expansion**: All-China coverage, 10% workforce in AI R&D, Hong Kong office opening with insurance license.
- **Profitability**: Net margin 28.5%, non-GAAP net income up 57.8% YoY, cash reserves RMB 3.42 billion.
- **Growth Outlook**: 20-30% YoY revenue growth, targeting >20% net margin, resilient to macro through AI ROI >1.

**【CEO Summary Section】**
- **Record Q2 2025 Results**: Total revenue reached RMB 1.07 billion (25.2% YoY, 10.3% QoQ), with net income surging 55.6% YoY to RMB 305 million. Cash reserves stood at RMB 3.42 billion.
- **Operational Breakthroughs**: Issued 7.9 million new policies, expanded coverage to all Chinese provinces, and invested 10% of workforce in AI R&D.
- **AI Innovations**: Integrated AI agents for workflow automation, RAG systems for insurance knowledge accuracy, and voice emotion recognition models for enhanced customer service.
- **Strategic Focus**: Driving inclusive insurance growth through policy alignment, AI-driven ecosystem expansion, and industry collaboration (e.g., China Online Insurance Consumer Insights Report).

**【CFO Financial Commentary】**
- **Revenue Growth**: Insurance distribution revenue up 29.6% YoY to RMB 350.6 million; system services revenue rose 23.8% YoY to RMB 718.2 million.
- **Profitability**: Net income margin expanded to 28.5% (vs. 22.9% YoY), with non-GAAP adjusted net income up 57.8% YoY to RMB 325.2 million.
- **Cost Management**: Operating expenses grew 16% YoY to RMB 772.2 million, with R&D investment rising 55.4% YoY to RMB 81.7 million.
- **Liquidity**: Generated RMB 453.2 million in operating cash flow, ending Q2 with RMB 3.42 billion in liquidity (99% YoY increase).

**【Q&A Key Highlights】**
- **Metrics & Growth**: Take rate ~10%, slight premium per policy decline due to product mix shift. Full-year revenue growth expected 20-30% YoY, net margin >20%.
- **Macro Resilience**: Focus on high-growth short-term health insurance; AI engine maintains ROI >1 despite macro uncertainty.
- **Compliance & Expansion**: Implemented clear auto-renewal policies, opened Hong Kong office, and acquired insurance license for international expansion.
- **Shareholder Returns**: Evaluating dividend policy but prioritizing strategic investments.
- **AI Impact**: AI agents reduced manual tasks by 30%, RAG improved response accuracy by 25%, and voice tech boosted satisfaction by 15%.


Actual		0.1507	0.1786	0.1658
Forecast
Surprise	0.00%	0.00%	0.00%	0.00%

Actual	--	149.31M	161.40M	168.03M
Forecast	--	--	--	--
Surprise	0.00%	0.00%	0.00%	0.00%

YB

YB fundamentals

YB Q4 2025 Earnings

Earnings Call

You can ask Aime

YB

YB fundamentals

YB Q4 2025 Earnings

Earnings Call

YB Earnings Call Summary for Q4/20258:00 AM on Mar 18, 2026

YB Earnings Call Summary for Q3/20257:00 AM on Dec 3, 2025

YB Earnings Call Summary for Q2/20258:00 AM on Aug 27, 2025

YB Earnings Call Summary for Q1/20258:00 AM on Jun 5, 2025

You can ask Aime